Search results for: Maria Lowe
Filter search results
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…be close to that value. Lower CET values would be inefficient as many cost-effective medicines will be denied access. Moreover, knowing the actual distribution of developers’ reserve ICERs from a…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
…the world’s population who live in low-income countries (LICs) and lower middle-income countries (LMICs). The lecture paper is available on the OHE website here. Further information on the BBAMC is…
Establishing a Reasonable Price for an Orphan Drug
11 September 2020
…and non-orphan drugs have to be considered to determine the reasonable price: (i) costs of research and development are likely to be lower for orphan drugs, and (ii) treatment populations…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…might be associated with a lower risk of COVID-19 infections (Jehi et al., 2020), stipulating this is not a causal effect and other factors likely contribute to this finding too….
Should We ‘Drop Dead’ from Health State Valuation?
10 December 2020
…considerable efforts devoted to developing new methods, the need to identify negative values continues to cause fundamental problems. For instance, there is no agreement on what the lowest negative value…
OHE at HESG Winter 2021
11 January 2021
…(IMD), and the census (to obtain ethnicity proportions by Lower Level of Super Output Areas (LLSOA).” The authors found that higher total practice funding was associated with increased mortality, which…
International Women’s Day: Why We #Choosetochallenge
8 March 2021
…disadvantages. For example: same work with lower salary; increasingly under-represented when moving up the stages of an academic career; gender bias in teaching evaluations; unequal share of household chores; and…
Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?
14 April 2021
…that health and consumption are not substitutes – i.e. they are either complements or independent attributes. If they were substitutes, higher consumption would be associated with lower utility from health…
Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic
21 April 2021
…from lower to higher-value vaccines according to new information and MSs’ unmet needs, as appropriate. The MSs should also develop strategies to avoid overreacting to very rare or ultra-rare safety…